Brokerages Set U.S. Physical Therapy, Inc. (NYSE:USPH) Target Price at $114.00

Shares of U.S. Physical Therapy, Inc. (NYSE:USPHGet Free Report) have earned an average recommendation of “Buy” from the five brokerages that are currently covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $114.00.

A number of equities analysts have recently weighed in on USPH shares. Bank of America raised shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and upped their price target for the stock from $100.00 to $115.00 in a research note on Monday, December 16th. JMP Securities started coverage on shares of U.S. Physical Therapy in a research report on Monday, December 16th. They set an “outperform” rating and a $113.00 target price on the stock. Barrington Research reiterated an “outperform” rating and set a $108.00 price target on shares of U.S. Physical Therapy in a research report on Thursday, November 21st. JPMorgan Chase & Co. upped their price target on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Tuesday, December 3rd. Finally, Citizens Jmp raised U.S. Physical Therapy to a “strong-buy” rating in a report on Monday, December 16th.

Read Our Latest Report on USPH

Insider Buying and Selling

In other U.S. Physical Therapy news, Director Bernard A. Harris, Jr. sold 2,000 shares of the business’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $92.95, for a total value of $185,900.00. Following the completion of the transaction, the director now directly owns 16,726 shares in the company, valued at approximately $1,554,681.70. The trade was a 10.68 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Carey P. Hendrickson sold 516 shares of the stock in a transaction on Monday, December 9th. The stock was sold at an average price of $96.25, for a total value of $49,665.00. Following the transaction, the chief financial officer now directly owns 20,469 shares in the company, valued at approximately $1,970,141.25. This represents a 2.46 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 7,412 shares of company stock worth $706,605 in the last ninety days. Insiders own 1.70% of the company’s stock.

Hedge Funds Weigh In On U.S. Physical Therapy

Several institutional investors have recently added to or reduced their stakes in the business. Canada Pension Plan Investment Board purchased a new stake in U.S. Physical Therapy in the 2nd quarter valued at about $28,000. Quest Partners LLC grew its holdings in U.S. Physical Therapy by 2,808.3% in the second quarter. Quest Partners LLC now owns 349 shares of the company’s stock valued at $32,000 after purchasing an additional 337 shares during the period. Quarry LP increased its position in U.S. Physical Therapy by 1,291.9% during the second quarter. Quarry LP now owns 515 shares of the company’s stock worth $48,000 after purchasing an additional 478 shares during the last quarter. KBC Group NV raised its stake in U.S. Physical Therapy by 68.6% during the third quarter. KBC Group NV now owns 774 shares of the company’s stock worth $66,000 after purchasing an additional 315 shares during the period. Finally, Benjamin F. Edwards & Company Inc. boosted its holdings in shares of U.S. Physical Therapy by 74.5% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 958 shares of the company’s stock valued at $89,000 after purchasing an additional 409 shares during the last quarter.

U.S. Physical Therapy Stock Down 0.8 %

USPH opened at $88.57 on Friday. The business has a 50 day simple moving average of $92.96 and a 200-day simple moving average of $88.98. U.S. Physical Therapy has a 12 month low of $76.18 and a 12 month high of $113.63. The stock has a market capitalization of $1.34 billion, a P/E ratio of 94.22, a P/E/G ratio of 4.23 and a beta of 1.48. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78.

U.S. Physical Therapy Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 15th were paid a dividend of $0.44 per share. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.99%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 187.23%.

U.S. Physical Therapy Company Profile

(Get Free Report

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Recommended Stories

Analyst Recommendations for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.